Brief: Fusion Antibodies Initiates Restructuring, Slashing Costs by 38% Including Headcount Reduction

Fusion Antibodies

30/04/2024 08:14

April 30 (Reuters) - Fusion Antibodies PLC  FAB.L :
    * YEAR-END TRADING STATEMENT
    * TOOK STEPS TO MEET CHALLENGES IN H1 THROUGH RESTRUCTURING
EXERCISE, REDUCING VARIOUS COSTS INCLUDING 38% REDUCTION IN
HEADCOUNT


 ((Reuters.Briefs@thomsonreuters.com;;))